Vanan Magimairajan Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2016

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vanan Magimairajan Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 01/2016
2	Turcot syndrome 01/2019 - 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016

Drug/Important Bio-Agent (IBA)

1	Tuberculin (PPD)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2016

Therapy/Procedure

1	Immunotherapy 01/2022
1	Therapeutics 01/2016